Free Trial
→ A deadly mistake in my prediction… (From Porter & Company) (Ad) Free NRSNW Stock Alerts

NeuroSense Therapeutics (NRSNW) SEC Filings & 10K Form

$0.20 -0.01 (-5.24%)
As of 03/11/2025 04:00 PM Eastern
Compare

Recent NeuroSense Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
02/19/2025
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
01/06/2025
9:40 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
12/12/2024
4:08 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
12/04/2024
7:32 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
10/31/2024
3:59 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
10/01/2024
5:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
09/30/2024
3:53 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2024
7:05 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/27/2024
7:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/24/2024
8:20 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/17/2024
4:25 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B3
06/17/2024
4:22 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
March 18th: Gold SHOCK? (Ad)

On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic… Businesses could get blindsided… The gold market could get rocked… And one man, millionaire trader Jeff Clark is pounding the table on one single stock before this event. Because this one single stock has shown his readers gains of 85% in 14 days, 120% in under 3 months, and even 222% in just 8 days. While the past is no sure indicator for the future… Those gains could pale in comparison to what's coming.

Click here now to see what's going on
05/28/2024
6:14 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
05/20/2024
3:16 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form F-1/A
05/20/2024
8:02 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
8:02 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
9:21 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:01 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
04/12/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
3:30 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 424B5
04/10/2024
8:00 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2024
7:32 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/08/2024
11:15 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form EFFECT
04/05/2024
8:28 AM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
4:10 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
04/04/2024
3:31 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/04/2024
3:37 PM		NeuroSense Therapeutics Ltd. (Filer)
NeuroSense Therapeutics (Filer)
Form POS AM
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NRSNW) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners
Former CIA to Trump – Will you Shut down this secret lab?
Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...
Paradigm Press | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...
Crypto Swap Profits | Sponsored
March 18th: Gold SHOCK?
On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...
InvestorPlace | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Musk’s real agenda in Washington…
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of ...
Porter & Company | Sponsored
DeFi Coin on Verge of Breakout!
We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years.
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored